Hem › Cancer (alla typer) › Texas › Dallas
Kliniska studier för Cancer (alla typer) i Dallas, TX
37 studier för Cancer (alla typer) söker deltagare vid platser i och runt Dallas (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RekryterarObservationsstudie
- UT Southwestern Medical Center, Dallas
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors
RekryterarFas 1
- GSK Investigational Site, Dallas
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
RekryterarFas 2/3
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Medical Center-Zale Lipshy University Hospital, Dallas
- och 1 fler
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
RekryterarFas 1
- NEXT Oncology, Dallas
- SCRI at Mary Crowley, Dallas
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RekryterarFas 3
- Texas Oncology-Baylor Charles A Sammons Cancer Center, Dallas
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekryterarFas 2/3
- Texas Oncology, Dallas
- Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas
- UT Southwestern Medical Center, Dallas
Connect for Cancer Prevention Study (Connect)
RekryterarObservationsstudieFriska volontärer välkomna
- Baylor Scott and White Health, Dallas
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
RekryterarFas 2
- UT Southwestern Medical Center, Dallas
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
RekryterarFas 1/2
- University of Texas - Southwestern Medical Center /ID# 271914, Dallas
Falcon Real World Evidence Registry
RekryterarObservationsstudieFriska volontärer välkomna
- Baylor Scott & White Health, Dallas
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekryterarFas 1
- Mary Crowley Cancer Research, Dallas
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RekryterarFas 3
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- Mary Crowley Cancer Research, Dallas
Perioperative FLOT(D) With Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Esophageal Cancer
RekryterarFas 1
- University of Texas Southwestern Medical Center, Dallas
Project: Every Child for Younger Patients With Cancer
RekryterarObservationsstudie
- Medical City Dallas Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RekryterarFas 3
- University of Texas Southwestern, Dallas
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
RekryterarFas 2
- University of Texas Southwestern Medical Center at Dallas, Dallas
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekryterarFas 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Study of ASP1002 in Adults for Treatment of Solid Tumors
RekryterarFas 1
- Mary Crowley Cancer Research Center, Dallas
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
RekryterarFas 1/2
- University of Texas - Southwestern Medical Center /ID# 274360, Dallas
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RekryterarFas 1
- Texas Oncology - Dallas - Worth Street /ID# 280064, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
RekryterarObservationsstudie
- Liver Center of Texas, Dallas
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
RekryterarFas 2
- University of Texas Southwestern Medical Center, Dallas
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekryterarFas 1/2
- Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas
- University of Texas Southwestern, Dallas
Feasibility Study of Personalized Ultra-fractionated Stereotactic Ablative Radiotherapy (PULSAR) for Cancers of the Central Lung
RekryterarTidig fas 1
- University of Texas Southwestern Medical Center, Dallas
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
RekryterarFas 1
- GSK Investigational Site, Dallas
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekryterar
- VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekryterarFas 1
- University of Texas Southwestern Medical Center /ID# 251974, Dallas
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RekryterarFas 1/2
- UT Southwestern Medical Center, Dallas
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
RekryterarFas 1
- GSK Investigational Site, Dallas
A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients
RekryterarFas 2
- Texas Oncology, Dallas
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
RekryterarObservationsstudie
- UT Southwestern Medical Centre, Dallas
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
RekryterarFas 1
- NEXT Dallas, Dallas
The TIOB - Collection of Patients' Biospecimens for Analysis of Immunological and Molecular Biomarkers.
RekryterarObservationsstudie
- Baylor University Medical Center - Dallas, Dallas
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
RekryterarFas 1
- NEXT Dallas, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
RekryterarFas 2
- University of Texas Southwestern Medical Center, Dallas
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Dallas
Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
RekryterarObservationsstudie
- UT Southwestern, Dallas
Cancer (alla typer)-studier i andra städer
- Houston, TX121 studier
- New York City, NY109 studier
- Boston, MA85 studier
- Los Angeles, CA74 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Washington, DC58 studier
- Durham, NC58 studier
- Chicago, IL51 studier
- Atlanta, GA49 studier
- Seattle, WA49 studier
- Arlington, VA48 studier
Andra studier i Dallas
- Bröstcancer55 studier
- Icke-småcellig lungcancer52 studier
- Metastaserande cancer42 studier
- Hjärtsvikt42 studier
- Prostatacancer36 studier
- Kolorektal cancer33 studier
- Övervikt30 studier
- Äggstockscancer28 studier
- Lungcancer27 studier
- Blåscancer27 studier
- Endometriecancer24 studier
- Njurcancer (renalcelskarcinom)23 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.